Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$367K Sell
2,496
-390
-14% -$63.4K 0.06% 147
2025
Q4
$563K Sell
2,886
-678
-19% -$161K 0.08% 120
2025
Q3
$1M Buy
3,564
+123
+4% +$31.3K 0.15% 75
2025
Q2
$752K Buy
3,441
+870
+34% +$140K 0.12% 90
2025
Q1
$359K Buy
2,571
+97
+4% +$15.8K 0.06% 141
2024
Q4
$412K Buy
2,474
+97
+4% +$17.2K 0.07% 131
2024
Q3
$405K Buy
2,377
+18
+0.8% +$2.61K 0.07% 131
2024
Q2
$333K Sell
2,359
-80
-3% -$9.94K 0.06% 140
2024
Q1
$306K Buy
+2,439
New +$279K 0.06% 147

Other funds holding ORCL

CFO4Life Group's ORCL Position: Q1 2026 in Review

CFO4Life Group reduced its Oracle (ORCL) stake by 14% in Q1 2026, selling an estimated $63.4K and leaving 2,496 shares worth $367K. The position accounts for 0.06% of the portfolio, ranked #147.

CFO4Life Group first reported a position in ORCL in Q1 2024 and has held it in 9 quarters since. The position peaked at $1M in Q3 2025. 3,471 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • CFO4Life Group held 2,496 shares of Oracle worth $367K as of Q1 2026.
  • CFO4Life Group sold 390 Oracle shares in Q1 2026, an estimated $63.4K.
  • Oracle made up 0.06% of CFO4Life Group's portfolio in Q1 2026, its #147 holding.
  • CFO4Life Group first reported a position in Oracle in Q1 2024 and has held it in 9 quarters since.
  • CFO4Life Group's Oracle position peaked at $1M in Q3 2025.
  • 3,471 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.